A molecular variant of angiotensinogen associated with preeclampsia
about
Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia.Administration of angiotensin II and a bradykinin B2 receptor blocker in midpregnancy impairs gestational outcome in guinea pigs.Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice.The Gene Variants of Maternal/Fetal Renin-Angiotensin System in Preeclampsia: A Hybrid Case-Parent/Mother-Control Study.Genetic determinants of human hypertension.Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world.CYP3A variation and the evolution of salt-sensitivity variantsDisentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene studyMolecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration.Classical Renin-Angiotensin system in kidney physiologyAngiotensinogen as a risk factor for essential hypertension in Japan.Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia.Genetic control of blood pressure and the angiotensinogen locusHypertension, genotype and oral contraceptives.Association between Angiotensinogen M235T Polymorphism and Preeclampsia in Iranian Pregnant Women.Genetics and blood pressure response to exercise, and its interactions with adiposity.Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system.Dexamethasone promotes hypertension by allele-specific regulation of the human angiotensinogen geneA genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region.Haplotypes of angiotensinogen in essential hypertensionApplications of polymorphisms and pharmacogenomics in obstetrics and gynecology.Estrogen Receptor Alpha (ESR1) Gene Polymorphisms in Pre-eclamptic Saudi Patients.Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsiaGenetic factors associated with small for gestational age birth and the use of human growth hormone in treating the disorder.Adipose tissue metabolism, diabetes and vascular disease--lessons from in vivo studies.The hypertensive disorders of pregnancy.Genes and the preeclampsia syndrome.Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women.Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.Vasodilator factors in the systemic and local adaptations to pregnancy.Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients.Angiotensinogen T235 expression is elevated in decidual spiral arteries.4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase.The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms.Hypertension in pregnancy: natural history and treatment options.
P2860
Q24798900-B3F14AE4-3057-4EEE-8E11-194925243C72Q33654741-1F7D7867-3B5E-4F2E-AFFF-B03EED5C7976Q33774507-76A3D6DF-399E-4AF8-8EAA-0ABF8C89557FQ33848380-B13A459B-EEB1-4299-8329-DAFA9FA49ADEQ33861718-22B39517-1690-4FEB-BC9B-1BFDA2291B1BQ33895023-5D529BA2-DE96-4FA6-B28B-92646C2D976EQ33908754-7E7F8B9A-D6F3-4434-A79F-423B05139EE5Q33909877-A3EF4644-68FD-4E3B-A364-65D68B568911Q33910537-1707A382-BF52-494D-BA2D-D9C8FC05DBCCQ34021020-A635022F-C2FC-4C81-80CD-6AB852F150B8Q34049233-A80895B5-F6B2-4C1B-9685-BE82E8F6316BQ34065655-C2D4C11F-14B6-4F9E-8608-CAAF71E09C4BQ34133604-26701B68-04D4-40C6-B48E-18B2B274F3FCQ34143985-19729CB3-4590-44F4-8966-78184005D4CCQ34498129-CC5EA07A-42F2-4674-A156-F66CCCA16456Q34609139-1A2E51B8-FAA0-403A-875A-CA7D901E110BQ34705582-98B0D370-38EB-4E2C-B263-E6B3E0A918C2Q34714724-8DE526C1-F389-4E45-B15B-6686756ACC20Q35020028-2593B84E-97CB-4B54-BFEB-DFBDDF1BD0E4Q35126691-25B134B7-0325-42FF-91CE-B9992647F87AQ35238460-D6050A6B-B565-4F2E-B6E8-4361F920ED4FQ35249140-53BD12EA-7EA2-4304-867D-8D423A4F6B8AQ35250479-73F7C54D-B9CC-4E7E-A251-2CB47446D13DQ35610515-6E7A749A-D818-44F0-9BEE-9FDD3C392AC4Q36111063-8DE1DE65-E7CD-4F17-A71B-F2FAA53CF46EQ36308550-ACD42C37-F091-46D5-BF16-F79163AE804FQ36437105-FA737597-2DE2-4A06-B89A-CB6246F95F42Q36511220-8A3D8B55-A659-4BC5-8FA6-0339F4750B22Q36904872-6F88E91B-7F52-431D-A616-B9F9CCE33D2DQ37053831-0893C1A6-08FF-494A-A429-39B1098E5A5EQ37175181-CE9CFB9A-CA8B-463B-B555-AC6FFAE3EF1FQ37205410-D8524795-628F-459D-A316-AADD404D4E4CQ37336090-4BA051DB-985E-406B-9CE7-DDF6D94BCE5BQ37365115-A9642B38-CCFF-4088-AE45-92662590F443Q37365783-C131D7D8-F139-4EC8-8FA7-D5636C67E3ADQ37371048-33668C16-365A-4A9F-9440-27B33CC2F7A5Q37372462-2EE4A043-C72D-4E1A-BBDC-5559ECBD664CQ37583185-D71EBDF8-BE37-4B18-A60C-18B10A90129BQ38014802-F4BD9E40-262A-4D6B-9106-BFDD9F9812F8Q38400715-08D0A02F-34E7-4D59-8B1E-03C71FF445A8
P2860
A molecular variant of angiotensinogen associated with preeclampsia
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A molecular variant of angiotensinogen associated with preeclampsia
@ast
A molecular variant of angiotensinogen associated with preeclampsia
@en
A molecular variant of angiotensinogen associated with preeclampsia
@en-gb
A molecular variant of angiotensinogen associated with preeclampsia
@nl
type
label
A molecular variant of angiotensinogen associated with preeclampsia
@ast
A molecular variant of angiotensinogen associated with preeclampsia
@en
A molecular variant of angiotensinogen associated with preeclampsia
@en-gb
A molecular variant of angiotensinogen associated with preeclampsia
@nl
prefLabel
A molecular variant of angiotensinogen associated with preeclampsia
@ast
A molecular variant of angiotensinogen associated with preeclampsia
@en
A molecular variant of angiotensinogen associated with preeclampsia
@en-gb
A molecular variant of angiotensinogen associated with preeclampsia
@nl
P2093
P2860
P921
P356
P1433
P1476
A molecular variant of angiotensinogen associated with preeclampsia
@en
P2093
C Namikawa
K Suzumori
M Ogasawara
P F Farrington
P2860
P2888
P356
10.1038/NG0593-59
P407
P577
1993-05-01T00:00:00Z
P5875
P6179
1021829165